CHINA LIBERAL EDUCATION HOLD (CLEU)

KYG2161Y1171 - Common Stock

0.1662  -0.02 (-11.45%)

After market: 0.173 +0.01 (+4.09%)

Fundamental Rating

2

Taking everything into account, CLEU scores 2 out of 10 in our fundamental rating. CLEU was compared to 67 industry peers in the Diversified Consumer Services industry. CLEU scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CLEU is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year CLEU has reported negative net income.
CLEU had a positive operating cash flow in the past year.
In multiple years CLEU reported negative net income over the last 5 years.
In multiple years CLEU reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of CLEU (-10.78%) is worse than 63.08% of its industry peers.
CLEU's Return On Equity of -11.43% is in line compared to the rest of the industry. CLEU outperforms 44.62% of its industry peers.
Industry RankSector Rank
ROA -10.78%
ROE -11.43%
ROIC N/A
ROA(3y)-3.77%
ROA(5y)0.91%
ROE(3y)-4.38%
ROE(5y)1.14%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CLEU does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

CLEU does not have a ROIC to compare to the WACC, probably because it is not profitable.
CLEU has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLEU has more shares outstanding
Compared to 1 year ago, CLEU has a worse debt to assets ratio.

2.2 Solvency

CLEU has an Altman-Z score of 6.46. This indicates that CLEU is financially healthy and has little risk of bankruptcy at the moment.
CLEU has a Altman-Z score of 6.46. This is amongst the best in the industry. CLEU outperforms 87.69% of its industry peers.
CLEU has a debt to FCF ratio of 24.18. This is a negative value and a sign of low solvency as CLEU would need 24.18 years to pay back of all of its debts.
CLEU has a Debt to FCF ratio (24.18) which is in line with its industry peers.
A Debt/Equity ratio of 0.02 indicates that CLEU is not too dependend on debt financing.
CLEU's Debt to Equity ratio of 0.02 is fine compared to the rest of the industry. CLEU outperforms 66.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 24.18
Altman-Z 6.46
ROIC/WACCN/A
WACC7.34%

2.3 Liquidity

A Current Ratio of 16.25 indicates that CLEU has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 16.25, CLEU belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
CLEU has a Quick Ratio of 16.22. This indicates that CLEU is financially healthy and has no problem in meeting its short term obligations.
CLEU's Quick ratio of 16.22 is amongst the best of the industry. CLEU outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 16.25
Quick Ratio 16.22

0

3. Growth

3.1 Past

CLEU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -63.44%.
Looking at the last year, CLEU shows a very negative growth in Revenue. The Revenue has decreased by -145.65% in the last year.
Measured over the past years, CLEU shows a decrease in Revenue. The Revenue has been decreasing by -9.71% on average per year.
EPS 1Y (TTM)-63.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1230.61%
Revenue 1Y (TTM)-145.65%
Revenue growth 3Y-16.86%
Revenue growth 5Y-9.71%
Sales Q2Q%-90.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLEU. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

CLEU's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 532.34
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CLEU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHINA LIBERAL EDUCATION HOLD

NASDAQ:CLEU (12/20/2024, 8:02:37 PM)

After market: 0.173 +0.01 (+4.09%)

0.1662

-0.02 (-11.45%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)11-07 2022-11-07/bmo
Earnings (Next)N/A N/A
Inst Owners0.42%
Inst Owner Change377.09%
Ins Owners35.28%
Ins Owner ChangeN/A
Market Cap46.34M
Analysts0
Price TargetN/A
Short Float %0.02%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF 532.34
P/OCF 2064.14
P/B 0.53
P/tB 0.57
EV/EBITDA N/A
EPS(TTM)-4.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.19%
OCF(TTM)0
OCFY0.05%
SpS-0.02
BVpS0.32
TBVpS0.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.78%
ROE -11.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM -1.66%
ROA(3y)-3.77%
ROA(5y)0.91%
ROE(3y)-4.38%
ROE(5y)1.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover-0.06
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 24.18
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.25
Quick Ratio 16.22
Altman-Z 6.46
F-Score4
WACC7.34%
ROIC/WACCN/A
Cap/Depr(3y)38.3%
Cap/Depr(5y)58.49%
Cap/Sales(3y)3.95%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-63.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1230.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-145.65%
Revenue growth 3Y-16.86%
Revenue growth 5Y-9.71%
Sales Q2Q%-90.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-168.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-98.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-99.69%
OCF growth 3YN/A
OCF growth 5YN/A